📰 Liminal Bioscience News
Page 9 - Liminal Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Liminal Bioscience. Real-time updates on events, politics, business and more.
May 28, 2021
/PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today...
May 17, 2021
Updated Business Strategy Focused on Small Molecule Therapeutics Kedrion to acquire, for a total of USD 17M, 2 plasma collection centers and an option to...
December 15, 2020
Liminal BioSciences Announces First Subject Dosed in Phase 1 Multiple Ascending Dose Clinical Trial of Fezagepras News provided by Share this article Share this article LAVAL, QC, and CAMBRIDGE, England, Dec. 15, 2020 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, today announced that the first subject has been dosed in the Companys fezagepras Phase 1 multiple ascending dose clinical trial in healthy v...